ALK and neuroblastoma: It was also reported that SUMOylation and glycosylation on the NPM‐ALK rearranged oncoprotein affected the stability and phosphorylation of the fused protein in neuroblastoma.34, 35 However, there has been no report indicating post‐translational EML4‐ALK methylation that may affect the oncogenic activity of this fusion protein.